Showing posts with label Approves. Show all posts
Showing posts with label Approves. Show all posts
Saturday, September 21, 2024

FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract Infections

›
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated ur...
Wednesday, September 4, 2024

FDA Approves Fruzaqla (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

›
Takeda announced the U.S. Food and Drug Administration (FDA) has approval of  Fruzaqla™ (fruquintinib), an oral targeted therapy for adults ...
Wednesday, August 28, 2024

FDA Approves Aurlumyn (iloprost) as the First Medication to Treat Severe Frostbite

›
The U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finge...
Tuesday, December 15, 2020

FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children

›
Bayer announced  that  the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (...
Thursday, June 27, 2019

FDA Approves Bavencio (avelumab) Plus Inlyta (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma

›
In continuation of my update on axitinib Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business a...
Friday, June 7, 2019

FDA Approves Avaclyr (acyclovir ophthalmic ointment) for the Treatment of Herpetic Keratitis

›
     The US Food and Drug Administration (FDA) has approved Fera Pharmaceuticals' New Drug Application (NDA) for Avaclyr (acyclo...
Thursday, June 6, 2019

FDA Approves Duaklir Pressair

›
In continuation of my update on formoterol  Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty pharmace...
Tuesday, March 26, 2019

FDA Approves Lonsurf (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

›
In continuation of my update on Lonsurf Taiho Oncology, Inc.  announced that the United States Food and Drug Administration (FDA) ha...